BioForce Nanosciences Price To Sales vs. Cash Flow From Operations
| BFNH Stock | USD 1.09 0.00 0.00% |
For BioForce Nanosciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of BioForce Nanosciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well BioForce Nanosciences Holdings utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between BioForce Nanosciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of BioForce Nanosciences Holdings over time as well as its relative position and ranking within its peers.
BioForce |
BioForce Nanosciences Cash Flow From Operations vs. Price To Sales Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining BioForce Nanosciences's current stock value. Our valuation model uses many indicators to compare BioForce Nanosciences value to that of its competitors to determine the firm's financial worth. BioForce Nanosciences Holdings is number one stock in price to sales category among its peers. It also is number one stock in cash flow from operations category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value BioForce Nanosciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for BioForce Nanosciences' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.BioForce Cash Flow From Operations vs. Price To Sales
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
BioForce Nanosciences |
| = | 3,841 X |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
BioForce Nanosciences |
| = | (77.77 K) |
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
BioForce Cash Flow From Operations Comparison
BioForce Nanosciences is currently under evaluation in cash flow from operations category among its peers.
BioForce Nanosciences Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in BioForce Nanosciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, BioForce Nanosciences will eventually generate negative long term returns. The profitability progress is the general direction of BioForce Nanosciences' change in net profit over the period of time. It can combine multiple indicators of BioForce Nanosciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. It sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, and mass merchandisers under the BioForce Eclipse brand, as well as through online and telemarketing. BIOFORCE NANOSCIENCES operates under Packaged Foods classification in the United States and is traded on OTC Exchange. It employs 2 people.
BioForce Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on BioForce Nanosciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of BioForce Nanosciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the BioForce Nanosciences' important profitability drivers and their relationship over time.
Use BioForce Nanosciences in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioForce Nanosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioForce Nanosciences will appreciate offsetting losses from the drop in the long position's value.BioForce Nanosciences Pair Trading
BioForce Nanosciences Holdings Pair Trading Analysis
The ability to find closely correlated positions to BioForce Nanosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioForce Nanosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioForce Nanosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioForce Nanosciences Holdings to buy it.
The correlation of BioForce Nanosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioForce Nanosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BioForce Nanosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BioForce Nanosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your BioForce Nanosciences position
In addition to having BioForce Nanosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Aggressive Funds Thematic Idea Now
Aggressive Funds
Funds or Etfs that attempt to achieve high capital gains by investing in companies with high growth potential and above average risk. The Aggressive Funds theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Aggressive Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in BioForce Pink Sheet
To fully project BioForce Nanosciences' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of BioForce Nanosciences at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include BioForce Nanosciences' income statement, its balance sheet, and the statement of cash flows.